Browse by People

Morris, K.A., Golding, J.F., Blesing, C., Evans, D.G., Ferner, R.E., Foweraker, K., Halliday, D., Jena, R., McBain, C., McCabe, M.G., Swampillai, A., Warner, N., Wilson, S., Parry, A. and Afridi, S. (2016) Toxicity profile of bevacizumab in the UK Neurofibromatosis Type 2 cohort. Journal of Neuro-oncology. ISSN 0167-594X (In Press)

Ferner, R.E., Shaw, A., Evans, D.G., McAleer, D., Halliday, D., Parry, A., Raymond F, L., Durie-Gair, J., Hanemann C, O., Hornigold, R., Axon, P.R. and Golding, J.F. (2014) Longitudinal evaluation of quality of life in 288 patients with Neurofibromatosis 2. Journal of Neurology, 26 (5). pp. 936-969. ISSN 0340-5354

Ferner, R.E., Golding, John F., Smith, M., Calonje, E., Jan, W., Sanjayanathan, V. and O'Doherty, M. (2008) [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Annals of Oncology, 19 (2). pp. 390-394. ISSN 0923-7534